Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban for Prevention of Post-angioplasty Thrombosis
NCT04489849Phase 4Unknown
- Sponsor
- National Taiwan University Hospital Hsinchu Branch
- Start
- Mar 2020
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apixaban in Vascular access thrombosis (VAT), sponsored by National Taiwan University Hospital Hsinchu Branch. Status: unknown.
02
Drugs
apixaban
03
Conditions
Vascular access thrombosis (VAT)
Beyond the preview
Go deeper on NCT04489849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04489849.